Online inquiry

IVTScrip™ mRNA-Human ABHD14B, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9364MR)

This product GTTS-WK9364MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ABHD14B protein. This product can be used in Liver bud hepatic cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001146314.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84836
UniProt ID Q96IU4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD14B, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK9364MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25152MR IVTScrip™ mRNA-Human ATG101, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATG101
GTTS-WK18992MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK21404MR IVTScrip™ mRNA-Human ALDH6A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALDH6A1
GTTS-WK6994MR IVTScrip™ mRNA-Human CD13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CD13
GTTS-WK26890MR IVTScrip™ mRNA-Human ASAH1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASAH1
GTTS-WK10763MR IVTScrip™ mRNA-Human ADPGK, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADPGK
GTTS-WK23677MR IVTScrip™ mRNA-Human ATP11B, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ATP11B
GTTS-WK13039MR IVTScrip™ mRNA-Human ACP2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACP2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW